IP Library › Granted Patent US 12,157,883
Granted Patent B2
US 12,157,883 · App. 15/970,728 · Granted Dec 3, 2024

DNA sequence modification-based gene drive

Inventors: Bruce A Hay (Pasadena, CA); Georg Oberhofer (Pasadena, CA); Tobin William Ivy (Pasadena, CA)
Assignee: California Institute of Technology
C12N15/102C12N5/14C12N5/16C12N15/905C12N15/907C12N15/74C12N15/80C12N15/8273C12N15/8274C12N15/8281C12N15/8283C12N15/8286C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,157,883
App. No.
15/970,728
Granted
Dec 3, 2024
Kind
B2
Abstract

Described herein are embodiments relating to manipulation of populations and sex ratio in populations through DNA sequence modifications.

Claims (20)

1. A vector, comprising:

a first gene sequence encoding a DNA sequence modifying enzyme, wherein the DNA sequence modifying enzyme induces one or more sequence modifications in an endogenous copy of an essential gene, wherein the DNA sequence modifying enzyme is Cas9 nuclease;

a first promoter operably linked to the first gene sequence encoding the DNA sequence modifying enzyme, wherein the first promoter is selected from the group consisting of a germline promoter, a male specific germline promoter, and a female specific germline promoter;

a second rescue transgene sequence;

a second promoter operably linked to the rescue transgene sequence;

a sequence encoding at least one guide RNA, wherein the guide RNA enables the Cas9 nuclease to target specific sequences within the essential gene,

one or more additional sequences that allow the vector to be positioned in a chromosome or an extra-chromosomal element that is different from the location of the endogenous copy of the essential gene comprise sequences that are not homologous to sequences flanking the endogenous copy of the essential gene, and

one or more cargo sequences;

wherein the one or more sequence modifications being cleavage of the essential gene resulting in the essential gene being rendered partially or wholly non-functional and resulting in a defect in survival, growth control, fertility, or differentiation in absence of the rescue transgene,

wherein a rescue of the defect occurs by the rescue transgene being positioned in a chromosomal or an extrachromosomal element that is different from the location of the endogenous copy of the essential gene,

wherein the rescue transgene is either a recoded copy of the essential gene or is a gene of unrelated sequence,

wherein the rescue transgene encodes a protein that is functionally equivalent to a protein encoded by the essential gene, and wherein the DNA sequence modifying enzyme does not modify the rescue transgene, and

wherein the vector is capable of performing a gene spread by increasing in relative frequency in a population following introduction into an organism by causing the death of those who inherit only non-functional alleles of the essential gene and fail to inherit the vector.

2. The vector of claim 1 , wherein the Cas9 nuclease cleaves and generates one or more single or double strand breaks in the endogenous copy of the essential gene.

3. The vector of claim 2 , wherein the one or more single or double strand breaks are repaired to create an altered sequence of the essential gene.

4. The vector of claim 1 , wherein the chromosome is an autosome, X chromosome, Y chromosome, or supernumerary chromosome.

5. The vector of claim 1 , wherein the extra-chromosomal element is a plasmid or a virus.

6. The vector of claim 1 , wherein the one or more cargo sequences comprise a one or more foreign gene sequences, or one or more alleles of an endogenous chromosomal or extra-chromosomal gene to which the vector has been linked through nearby insertion on the chromosome or extra-chromosomal element that carries the endogenous allele of interest.

7. The vector of claim 1 , wherein the one or more additional sequences is selected from the group consisting of transposase binding site, LTRs, recombinase binding site, and a sequence with homology to a desired location on the chromosome or the extra-chromosomal element.

8. The vector of claim 1 , wherein the Cas9 nuclease comprises at least one nuclease domain and one or more DNA binding domains.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2018
From: HAY, BRUCE A.; OBERHOFER, GEORG; IVY, TOBIN WILLIAM
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 046309/0933 →
Continuity (2)
Provisional Application 62502338 · May 5, 2017
Related Publication 20180320164A1 · Nov 8, 2018
Cited By (1)
US 12,577,583